Log in

Zynex Stock Forecast, Price & News

+0.23 (+1.62 %)
(As of 10/23/2020 12:00 AM ET)
Today's Range
Now: $14.47
50-Day Range
MA: $16.30
52-Week Range
Now: $14.47
Volume511,400 shs
Average Volume812,731 shs
Market Capitalization$502.20 million
P/E RatioN/A
Dividend YieldN/A
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and TENSWave, a dual channel TENS device. The company also supplies electrodes for the delivery of electrical current to the body and batteries for use in electrotherapy products; and distributes Comfortrac for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers blood volume monitor, a non-invasive medical device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.30 out of 5 stars

Industry, Sector and Symbol

Industry Medical Devices



Sales & Book Value

Annual SalesN/A



Market Cap$502.20 million
Next Earnings DateN/A
OptionableNot Optionable
+0.23 (+1.62 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ZYXI News and Ratings via Email

Sign-up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Zynex (NYSE:ZYXI) Frequently Asked Questions

How has Zynex's stock been impacted by COVID-19?

Zynex's stock was trading at $11.09 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ZYXI shares have increased by 30.5% and is now trading at $14.47.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Zynex?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zynex in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Zynex

How were Zynex's earnings last quarter?

Zynex, Inc. (NYSE:ZYXI) issued its earnings results on Tuesday, July, 28th. The company reported $0.09 earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of $0.09. The business had revenue of $19.26 million for the quarter, compared to analyst estimates of $19.12 million.
View Zynex's earnings history

What price target have analysts set for ZYXI?

2 Wall Street analysts have issued 12 month target prices for Zynex's shares. Their forecasts range from $28.00 to $28.00. On average, they expect Zynex's share price to reach $28.00 in the next twelve months. This suggests a possible upside of 93.5% from the stock's current price.
View analysts' price targets for Zynex

Who are some of Zynex's key competitors?

What other stocks do shareholders of Zynex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zynex investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), AbbVie (ABBV), Moderna (MRNA), Tesla (TSLA), Zoom Video Communications (ZM), Docusign (DOCU), Livongo Health (LVGO), Inovio Pharmaceuticals (INO) and Abbott Laboratories (ABT).

Who are Zynex's key executives?

Zynex's management team includes the following people:
  • Mr. Thomas Sandgaard, Founder, Pres, CEO & Chairman (Age 61, Pay $523.04k)
  • Mr. Daniel J. Moorhead, Chief Financial Officer (Age 48, Pay $352.86k)
  • Mr. Joseph Papandrea, Chief Operating Officer (Age 47, Pay $272.31k)
  • Ms. Chelle Van Burkleo, VP of Sales
  • Mr. Joachim Sandgaard, Information Systems Mang.

What is Zynex's stock symbol?

Zynex trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZYXI."

How do I buy shares of Zynex?

Shares of ZYXI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Zynex's stock price today?

One share of ZYXI stock can currently be purchased for approximately $14.47.

How big of a company is Zynex?

Zynex has a market capitalization of $502.20 million. Zynex employs 283 workers across the globe.

What is Zynex's official website?

The official website for Zynex is www.zynex.com.

How can I contact Zynex?

The company can be reached via phone at 303-703-4906.

This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.